Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2006Expert Opinion on Therapeutic Patents

Progress in the discovery of Factor Xa inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAgustin Casimiro‐GarciaPfizer (United States)DDDanette A. DudleyPfizer (United States)RHRonald J. HeemstraPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Casimiro‐Garcia et al. (2006) studied this question.

synapsesocial.com/papers/6a7100cae71d69abee08fcadhttps://doi.org/10.1517/13543776.16.2.119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors1994 · 179 citations
  2. 2Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs2001 · 12 citations